Narcolepsy Drugs Market is Striving in Worldwide with Top Key Players: Ligand Pharmaceuticals, Addrenex Pharmaceuticals
According to the report by Allied Market Research, the global narcolepsy drugs market is estimated to register a CAGR of 10.3% from 2019 to 2026. The research helps leading players and startups to devise new strategies based on current market trends and changing dynamics. Competitive landscape is mentioned in the report based on business segments, products portfolio, and strategic moves & developments of leading market players. Detailed segmentation assists in determining growing segments and determining further steps to capitalize on lucrative segments. Regional landscape is helpful in determining opportunities and driving factors of each region and taking further steps.
The electroencephalography devices segment accounted for more than one-fifth of the total market share in 2017.
Click Here To Access Free Sample Report @ https://www.alliedmarketresearch.com/request-sample/3612
Narcolepsy is a chronic disabling condition with symptoms such as cataplexy, excessive daytime sleepiness (EDS), sleep paralysis, hypnogogic hallucinations, and disrupted nocturnal sleep. Most of the narcolepsy drugs are used to treat symptoms related to cataplexy and excessive daytime sleepiness.
The global narcolepsy drug market size has witnessed significant growth in the past few years, owing to rise in awareness regarding the benefits of early diagnosis of narcolepsy drug and availability of wide variety of narcolepsy drugs contribute toward the market growth. Governments of countries such as India and South Africa are promoting the awareness of importance of narcolepsy, which is further expected to boost the narcolepsy drug market growth during the forecast period. However, stringent government regulations toward the approval for novel narcolepsy drugs is projected to hamper the market growth during the forecast period. Conversely, untapped markets in the developing countries are expected to offer remunerative opportunities for the market players in the near future.
Based on narcolepsy disease type, the narcolepsy drugs market is segmented into daytime extreme sleepiness, cataplexia, and others. Daytime extreme sleepiness segment is the highest revenue generator in the overall narcolepsy drugs market, as large number of people suffering from narcolepsy and other sleep disorders have a higher risk of this symptom, thus increasing the demand for narcolepsy drugs. However, the cataplexia segment is expected to grow at the highest rate, as patients suffering from cataplexia experience loss of muscle control, and almost 70% of narcolepsy patients are found to have this symptom.
Inquire Before Buying @ https://www.alliedmarketresearch.com/purchase-enquiry/3612
Based on therapeutics type, the narcolepsy drugs market is segmented into central nervous system stimulants, tricyclic antidepressants, sodium oxybate, selective serotonin reuptake inhibitor, and others. The sodium oxybate segment held the highest share global narcolepsy drugs market in the 2018, as these drugs are highly effective to treat daytime extreme sleepiness and cataplexy. However, selective serotonin reuptake inhibitor segment is expected to grow at the highest rate due to increase in R&D activities for the development of these type of drugs by the key players.
The Major Key Players Are:
• Ligand Pharmaceuticals
• Addrenex Pharmaceuticals
• Shire Plc
• Teva Pharmaceutical Industries Ltd.
• Arena Pharmaceuticals
• Jazz Pharmaceuticals Plc
Access Full Report @ https://www.alliedmarketresearch.com/narcolepsy-drugs-market
Portland, OR, United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Allied Market Research (AMR) is a market research and business-consulting firm of Allied Analytics LLP, based in Portland, Oregon. AMR offers market research reports, business solutions, consulting services, and insights on markets across 11 industry verticals. Adopting extensive research methodologies, AMR is instrumental in helping its clients to make strategic business decisions and achieve sustainable growth in their market domains. We are equipped with skilled analysts and experts, and have a wide experience of working with many Fortune 500 companies and small & medium enterprises.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Narcolepsy Drugs Market is Striving in Worldwide with Top Key Players: Ligand Pharmaceuticals, Addrenex Pharmaceuticals here
News-ID: 2162983 • Views: 280
More Releases from Allied Market Research
Orthopedic Prosthetics Market Will Expand in the Coming Decade
Orthopedic Prosthetics Market report analyses the prospects in the market for several shareholders and aspirants by identifying the high-growth segments, main actions approved by them and Orthopedic Prosthetics market recent progressions. The Orthopedic Prosthetics market report is prepared after fundamental levels of research regarding the Orthopedic Prosthetics Industry. Orthopedic Prosthetics Market by Product (Upper Extremity Prosthetics, Lower Extremity Prosthetics, Liners, Sockets, and Modular Components) Technology (Conventional, Electric Powered, and Hybrid
Orthopedic Operating Tables Market Challenges and New Trends
According to a new report published by Allied Market Research, titled, ” Orthopedic Operating Tables Market by Technology (Non-powered Operating Tables and Powered Operating Tables) and End Users (Hospitals and Ambulatory Surgical Centers (ASCs)) – Global Opportunity and Forecast, 2019-2026”. The Global market size of Orthopedic Operating Tables market is $XX million in 2018 with XX CAGR, and it is expected to reach $XX million by the end of 2027 with
Orthopedic Consumables Market Analysis of The Current and Emerging Trends
According to a new report published by Allied Market Research, titled, ” Orthopedic Consumables Market by Product (Surgical Orthopedic Consumables, Wound-Management Orthopedic Consumables, and Others) and End Users (Hospitals, Clinics, Ambulatory Surgical Centers (ASCs), and Others) – Global Opportunity and Forecast, 2019-2026 The Global market size of Orthopedic Consumables market is $XX million in 2018 with XX CAGR, and it is expected to reach $XX million by the end of 2027
Intraosseous Infusion Device Market Challenges and New Trends
According to a new report published by Allied Market Research, titled, “Intraosseous Infusion Device Market by Product Type (FAST1 device, Dieckmann Modified Needle, BIG device, EZ-IO device, Jamshidi Needle, FASTx device, and NIO), by Technology (Battery Powered Driver, Manual IO Needles, and Impact Driven Devices), by Route of Administration (Distal Femur, Sternum, Distal & Proximal Tibia, Calcaneus, and Head of Humerus), by End User (Hospitals, Emergency Medical Services, Ambulatory Surgical
More Releases for Narcolepsy
2018 Global Narcolepsy Drug Industry Depth, Size,Status and Forecast
The report provides a comprehensive analysis of the Narcolepsy Drug industry market by types, applications, players and regions. This report also displays the 2013-2023 production, Consumption, revenue, Gross margin, Cost, Gross, market share, CAGR, and Market influencing factors of the Narcolepsy Drug industry in USA, EU, China, India, Japan and other regions Get Sample@ https://www.researchbeam.com/2018-global-narcolepsy-drug-industry-depth-research-report-market/request-sample Market Analysis by Players: This report includes following top vendors in terms of company basic information, product
A Comprehensive Study exploring Narcolepsy Therapeutics Market
A new research study from HTF MI with title Global Narcolepsy Therapeutics Market Size, Status and Forecast 2025 provides an in-depth assessment of the Narcolepsy Therapeutics including key market trends, upcoming technologies, industry drivers, challenges, regulatory policies, key players company profiles and strategies. The research study provides forecasts for Narcolepsy Therapeutics investments till 2025. Access Sample Copy @: https://www.htfmarketreport.com/sample-report/1181484-global-narcolepsy-therapeutics-market-4 If you are involved in the Narcolepsy Therapeutics industry or intend
Narcolepsy Market entry and market expansion strategies
MarketResearchReports.Biz adds “Global Narcolepsy Market Share, Size, Trends and Forecast Market Research Report” reports to its database. This report provides a strategic analysis of the Narcolepsy and the growth estimates for the forecasted period. GlobalData's clinical trial report, Narcolepsy Global Clinical Trials Review, H1, 2018" provides an overview of Narcolepsy clinical trials scenario. This report provides top line data relating to the clinical trials on Narcolepsy. Report includes an overview of
Narcolepsy Treatment Pipeline Review H2 2017
Pune, India, 26th October 2017: WiseGuyReports announced addition of new report, titled “Narcolepsy - Pipeline Review, H2 2017”. Summary Narcolepsy is a sleep disorder that causes excessive sleepiness and frequent daytime sleep attacks. Symptoms of narcolepsy include excessive daytime sleepiness (EDS), cataplexy, hallucinations and sleep paralysis. Narcolepsy treatment includes lifestyle change, medication and counseling. Report Highlights Pharmaceutical and Healthcare latest pipeline guide Narcolepsy - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics
Narcolepsy Market Pipeline Review, H2 2017
"The Report Narcolepsy - Pipeline Review, H2 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Narcolepsy - Pipeline Review, H2 2017, provides an overview of the Narcolepsy (Central Nervous System) pipeline landscape. Narcolepsy is a sleep disorder that causes excessive sleepiness and frequent daytime sleep attacks. Symptoms of narcolepsy include excessive daytime
Narcolepsy - Pipeline Review, H1 2017 - Pharmaceutical Report
Narcolepsy is a sleep disorder that causes excessive sleepiness and frequent daytime sleep attacks. Symptoms of narcolepsy include excessive daytime sleepiness (EDS), cataplexy, hallucinations and sleep paralysis. Narcolepsy treatment includes lifestyle change, medication and counseling. Request Free Sample Report - http://www.marketresearchhub.com/enquiry.php?type=S&repid=1068443 Report Highlights Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Narcolepsy - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Narcolepsy (Central Nervous System), complete